BHLHA9
Class A basic helix-loop-helix protein 9
Also known as: BHA09_HUMAN, BHLHF42
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTU4
- Gene
- BHLHA9
- Ensembl
- ENSG00000205899
- Chromosome
- 17
- Canonical length
- 235 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene is a member of the basic helix-loop-helix family. The encoded protein is a transcription factor involved in limb development. Mutations in this gene have been associated with mesoaxial synostotic syndactyly Malik-Percin type (MSSD). Copy number variation of a locus containing this gene has been linked to a form of split-hand/foot malformation with long bone deficiency (SHFLD3). [provided by RefSeq, Mar 2015]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q7RTU4|BHLHA9
1 MLRGAPGLGL TARKGAEDSA EDLGGPCPEP GGDSGVLGAN GASCSRGEAE EPAGRRRARP
61 VRSKARRMAA NVRERKRILD YNEAFNALRR ALRHDLGGKR LSKIATLRRA IHRIAALSLV
121 LRASPAPRGP CGHLECHGPA ARGDTGDTGA SPPPPAGPSL ARPDAARPSV PSAPRCASCP
181 PHAPLARPSA VAEGPGLAQA SGGSWRRCPG ASSAGPPPWP RGYLRSAPGM GHPRSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BHLHA9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 1.3 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 1.3 nTPM
- amygdala: 0.6 nTPM
- hypothalamus: 0.6 nTPM
- hippocampal formation: 0.4 nTPM
- cerebellum: 0.2 nTPM
- liver: 0.2 nTPM
Single-cell type
- other brain neurons: 1.5 nCPM
- brain excitatory neurons: 1 nCPM
- brain inhibitory neurons: 0.6 nCPM
- late spermatids: 0.4 nCPM
- salivary ionocytes: 0.4 nCPM
- basal prostatic cells: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 5.1 nTPM
- pons: 4 nTPM
- hypothalamus: 3.4 nTPM
- medulla oblongata: 2.5 nTPM
- basal ganglia: 2.2 nTPM
- white matter: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BHLHA9.
Disease | AllUniProt
Conditions BHLHA9 is implicated in, by any mechanism.
- Split-hand/foot malformation with long bone deficiency 3 (SHFLD3) MIM:612576
- Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) MIM:609432
- Camptosynpolydactyly, complex (CCSPD) MIM:607539
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 95 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mesoaxial synostotic syndactyly with phalangeal reduction
- Camptosynpolydactyly, complex
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein heterodimerization activity
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BHLHA9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BHLHA9 as an antibody target. Whether an autoantibody or antibody against BHLHA9 could matter depends on whether native BHLHA9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BHLHA9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BHLHA9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...